- Home
- CHE
CHE
Chemed Corp
as 05-09-2025 9:48am EST
Chemed Corp operates subsidiaries in two main segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue. It provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The vast majority of the segment's revenue is received from the Medicare and Medicaid reimbursement programs. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers. Chemed generates the majority of its revenue from business in the United States.
| Founded: | 1970 | Country: | United States |
| Employees: | N/A | City: | CINCINNATI |
| Market Cap: | 8.8B | IPO Year: | N/A |
| Target Price: | $674.00 | AVG Volume (30 days): | 129.5K |
| Analyst Decision: | Buy | Number of Analysts: | 1 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 20.53 | EPS Growth: | 10.48 |
| 52 Week Low/High: | $512.12 - $623.61 | Next Earning Date: | 04-23-2025 |
| Revenue: | $2,488,997,000 | Revenue Growth: | 8.52% |
| Revenue Growth (this year): | 9.04% | Revenue Growth (next year): | 6.68% |
Stock Insider Trading Activity of Chemed Corp (CHE)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| LEE SPENCER S | CHE | executive vice president | May 7 '25 | Sell | $577.86 | 1,500 | $866,790.00 | 16,127 | |
| MCNAMARA KEVIN J | CHE | president and CEO | May 5 '25 | Sell | $576.45 | 1,500 | $864,675.00 | 101,197 | |
| MCNAMARA KEVIN J | CHE | president and CEO | Mar 31 '25 | Sell | $615.33 | 1,000 | $615,330.00 | 101,197 | |
| MCNAMARA KEVIN J | CHE | president and CEO | Mar 6 '25 | Sell | $593.67 | 2,000 | $1,187,340.00 | 101,197 | |
| LEE SPENCER S | CHE | executive vice president | Mar 3 '25 | Sell | $592.25 | 1,326 | $785,323.50 | 16,127 |
Latest Chemed Corp News
CHE Breaking Stock News: Dive into CHE Ticker-Specific Updates for Smart Investing
StockStory
a day ago
Q1 Earnings Highs And Lows: AdaptHealth (NASDAQ:AHCO) Vs The Rest Of The Senior Health, Home Health & Hospice Stocks
Argus Research
3 days ago
CHE: Raising target price to $634.00
MT Newswires
3 days ago
Chemed Insider Sold Shares Worth $864,675, According to a Recent SEC Filing
Business Wire
3 days ago
Chemed Corporation to Present at the Bank of America Securities Health Care Conference 2025
Zacks
7 days ago
OPCH vs. CHE: Which Stock Is the Better Value Option?
StockStory
7 days ago
3 Cash-Heavy Stocks Skating on Thin Ice
StockStory
10 days ago
3 Dawdling Stocks That Concern Us
Zacks
14 days ago
CHE Stock Falls Despite Q1 Earnings & Revenue Beat, Gross Margin Declines
Compare CHE vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CHE Chemed Corp - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.